The NIH Pharmacogenomics Research Network (PGRN)* is making comments on the Genetic Testing Registry (GTR) after consultation with our membership and other leaders in the genetics community. NIH’s vision of Personalize

First Page		Document Content
Date: 2013-10-22 12:03:37 Health Pharmacology Biology Pharmacogenetics Genetics Pharmacogenomics Personalized medicine Genetic testing National Institutes of Health Medicine Genomics Pharmacy		The NIH Pharmacogenomics Research Network (PGRN)* is making comments on the Genetic Testing Registry (GTR) after consultation with our membership and other leaders in the genetics community. NIH’s vision of Personalize Add to Reading List Source URL: osp.od.nih.gov Download Document from Source Website File Size: 18,28 KB Share Document on Facebook

	B A S I C S Basics of Pharmacogenomics DocID: 1vjVD - View Document
	Clinical pharmacology and Pharmacogenomics Challenges Patients respond highly variably to drug therapy. The reason may be pharmacokinetic and/or pharmacodynamic differences between patients, due to differences in metabol DocID: 1uw1R - View Document
	Emily Witt Pharmacogenomics of Depression Therapy HUMBIO 158G March 14, 2014 DocID: 1urEc - View Document
	Emily Doughty BMI 258 Spring 2013 Final Report The Future of Medicine: Challenges for Pharmacogenomics in the Clinic DocID: 1uhZc - View Document
	Sydney Beache Human Biology 158G The Economic, Ethical, and Social Implications of the Pharmacogenomics Movement I. Introduction to Pharmacogenomics While the term “pharmacogenetics” has been in existence for roughly DocID: 1u9i0 - View Document